The team led by Canè, Paladino, Conte, and colleagues has delved into the multifaceted roles of HMGA proteins within the nervous system. These non-histone chromosomal proteins are known to bind AT-rich regions of DNA, altering chromatin conformation and thereby influencing the transcriptional landscape of cells. Their aberrant expression has recently been linked to the initiation and progression of various cancers, but this study extends their significance to neural contexts, specifically focusing on brain tumor formation and neurodegenerative mechanisms.

One of the remarkable findings from this research is the dualistic role HMGA proteins play depending on cellular context. In brain tumors, HMGA overexpression appears to drive oncogenic processes by promoting cellular proliferation, enhancing stem-like properties of tumor cells, and evading apoptotic signals. Mechanistically, HMGA proteins facilitate the chromatin remodeling necessary for oncogenic transcription factors to access their target genes, thus sustaining tumor growth and resistance to therapy.

Conversely, in neurodegeneration, the study reveals that HMGA proteins contribute to neuronal vulnerability. Dysregulation of HMGA expression disrupts the delicate equilibrium of gene networks that govern neuronal survival and plasticity. This disruption potentially accelerates processes such as protein aggregation, synaptic dysfunction, and ultimately, neuronal death which are hallmarks of neurodegenerative diseases like Alzheimer’s and Parkinson’s.

The authors further illuminate how HMGA-mediated chromatin remodeling intersects with epigenetic modifications in both pathological states. For example, HMGA proteins appear to recruit or modulate histone modifiers and DNA methylation machinery, orchestrating comprehensive epigenetic changes that exacerbate disease progression. These insights provide promising avenues for therapeutic targeting, focusing on reversing or modulating HMGA activity to restore healthy gene expression patterns.

Technically, the researchers employed advanced genomic and proteomic analyses, including chromatin immunoprecipitation sequencing (ChIP-seq) and RNA sequencing, to map the binding landscape and downstream gene networks controlled by HMGA proteins in neural cells. Their integrative approach highlighted dozens of novel neural-specific HMGA targets implicated in cellular stress responses, development, and metabolic regulation.

This seminal work not only advances our molecular understanding of brain tumorigenesis and neurodegeneration but also underscores the potential of HMGA proteins as biomarkers and therapeutic targets. The capacity to modulate chromatin architecture selectively in affected neural populations could open revolutionary treatment strategies for some of the most devastating brain disorders.

As the neuroscience community digests these findings, future research will undoubtedly build on this foundation to explore targeted modulation of HMGA functions, ultimately aiming to halt or reverse pathogenic processes with high specificity.

Subject of Research: HMGA proteins’ role in brain tumorigenesis and neurodegeneration

Article Title: HMGA proteins in the nervous system: role in brain tumorigenesis and neurodegeneration

Article References:

Canè, C., Paladino, S., Conte, A. et al. HMGA proteins in the nervous system: role in brain tumorigenesis and neurodegeneration. Cell Death Discov. (2026). https://doi.org/10.1038/s41420-026-03242-4

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41420-026-03242-4

Emerging research has illuminated the importance of ribosome biogenesis in brain development, revealing that its regulation directly correlates with alterations in neural stem cell dynamics. Recent studies illustrate that any inadequacy in the ribosome assembly process can lead to detrimental effects, including abnormal cell proliferation and developmental defects. The demand for ribosomes peaks during critical stages of neurogenesis, indicating that cells must precisely coordinate ribosome production to maintain proper developmental trajectories and to prevent oncogenic transformations.

At the molecular level, the regulation of ribosome biogenesis is mediated by a plethora of factors, including ribosomal RNA processing elements and a variety of assembly proteins, which work collectively to ensure proper ribosome formation. Investigations have highlighted the significance of N6-methyladenosine (m6A), a prevalent post-transcriptional modification found in messenger RNA (mRNA), in modulating both gene expression and, indirectly, ribosome biogenesis. Despite its significance, the underlying mechanisms of m6A’s influence on cellular functions and protein synthesis remain inadequately explored, particularly regarding how cells adapt to these modifications during different biological scenarios.

A seminal study publicized in the journal Science Advances has significantly advanced our understanding of ribosome biogenesis and its regulation by m6A modifications. This research was spearheaded by a collaboration led by distinguished scientists, Professor Zhou Tao of the Shenzhen Institute of Advanced Technology and Professor Shen Bin from Nanjing Medical University. Their groundbreaking findings indicate that VIRMA, a protein that demonstrates high expression levels in both the embryonic brain and various cancer types, plays an essential role in controlling ribosomal biogenesis during brain development.

VIRMA operates as a crucial scaffold protein in the m6A methyltransferase complex and is noted for being its largest constituent. Using advanced methodologies, including conditional knockout mice and neural stem cell models, the research team undertook an in-depth analysis of VIRMA’s function. By employing techniques such as RNA sequencing and multi-omics approaches, they elucidated how the absence of VIRMA impairs the m6A modification levels on mRNAs specifically associated with ribosome biogenesis.

The critical finding of this research is that the depletion of VIRMA induces a considerable decrease in m6A levels on essential mRNA. This disruption directly impacts the expression of genes that are vital for ribosome assembly. Furthermore, the study elucidated that by prolonging the half-lives of mRNAs linked to ribosome biogenesis, VIRMA knockout leads to interruptions in downstream processes, which are crucial for normal developmental patterns. These interruptions subsequently activate a stress response mediated by p53, which is recognized for its role in tumor suppression, further amplifying the consequences of impaired ribosome production.

This cascade of molecular dysfunctions results in widespread disturbances in protein translation and ultimately culminates in inhibited cell growth and proliferation. The impact on development becomes evident as it manifests in a variety of severe defects. Hence, the influence of VIRMA on ribosome biogenesis emerges not just as a regulatory factor, but rather as a linchpin essential for maintaining proper brain developmental processes.

To extend the relevance of their findings, the researchers delved into preliminary analyses utilizing human cancer cells, specifically examining models of breast cancer (MCF7) and cervical cancer (HeLa). Their observations revealed similar defects in ribosome biogenesis in cancer cells deprived of VIRMA, suggesting that the regulatory mechanisms identified through this study may also extend across various cell types. This raises intriguing possibilities about the evolutionarily conserved nature of these processes, indicating that the fundamental importance of ribosome biogenesis regulation transcends between normal and pathological cellular environments.

Moreover, this study enriches the existing body of knowledge surrounding regulatory networks, highlighting the intricate relationships that govern protein synthesis and their broader implications for cell biology. By emphasizing the role of mRNA modifications, particularly m6A, the findings illuminate how these subtle chemical changes can resonate through cellular systems, fundamentally altering processes critical to development and, by extension, disease occurrence.

The overarching implications of such research extend beyond simple cellular mechanisms. Understanding how m6A modifications can influence pathways critical to development and cancer provides insights that could inform therapeutic strategies aimed at mitigating developmental defects or targeting cancerous growths. Continued exploration into the molecular underpinnings of ribosome biogenesis and its regulators, like VIRMA, will undoubtedly pave the way for innovative approaches in developmental biology and oncology, revealing further layers of complexity in the regulation of gene expression and its ramifications on health and disease.

In conclusion, this investigation significantly bridges gaps in our understanding of how m6A modifications orchestrate critical biological processes and underscores the importance of ribosome biogenesis in both development and cancer biology. As science advances, integrating these discoveries into broader biological frameworks will enhance our ability to manipulate these processes for therapeutic benefit.

Subject of Research: Ribosome Biogenesis and m6A Modifications in Neurodevelopment and Cancer
Article Title: VIRMA-mediated m6A modification regulates forebrain formation through modulating ribosome biogenesis
News Publication Date: 27-Jun-2025
Web References: http://dx.doi.org/10.1126/sciadv.adq9643
References: Science Advances
Image Credits: None

Keywords

Ribosome biogenesis, m6A modification, neural stem cells, brain development, cancer biology.